2018 International Congress

Monday, October 8, 2018

1:15pm-2:45pm

L-Dopa Responsiveness is Correlated to Fluorodeoxyglucose Metabolism and Dopamine Transporter Availability in Parkinson’s Disease

D. Su, W. Hu, X. Zhao, Z. Liu, H. Ma, J. Zhou, T. Feng (Beijing, China)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

Lack of TMEM230 mutations in patients with familial and sporadic Parkinson’s disease in a Taiwanese population

T. Fan, C. Lin, H. Lin, M. Chen, R. Wu (Taoyuan, Taiwan)

Parkinson's Disease: Genetics  ·  Hall 3FG

1:15pm-2:45pm

Levels of plasma alpha-synuclein as measured using Single Molecule Array technology is higher in Parkinson’s disease compared to controls and is not influenced by LRRK2 genotype

YJ. Tan, A. Ng, ZH. Lu, S. Ng, E. Ng, F. Setiawan, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

Parkinson's Disease: Genetics  ·  Hall 3FG

1:15pm-2:45pm

Levodopa and subthalamic stimulation do not have the same effect on subjective cost for distal and axial efforts in Parkinson’s disease

C. Atkinson-Clement, E. Cavazzini, C. Baunez, A. Zénon, S. Pinto, F. Fluchère, E. Robin, T. Witjas, JP. Azulay, A. Eusebio (Aix-en-Provence, France)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Levodopa-induced dyskinesia in Parkinson’s disease: Sleep matters

N. Amato, M. Manconi, J.C. Möller, S. Sarasso, P. Stanzione, C. Städler, A. Kaelin-Lang, S. Galati (Lugano, Switzerland)

Parkinson's Disease: Pathophysiology  ·  Hall 3FG

1:15pm-2:45pm

Listen to the heart: Do loud vagal rhythms disharmonize the autonomic symphony in Parkinson’s disease patients with the LRRK2 mutation?

C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schuele, S. Goldman, M. Estévez Báez, P. Stein, A. Lang, H. Jelinek, A. Machado García (Havana, Cuba)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Long-term and dopamine dependent dynamics of subthalamic nucleus local field potentials in Parkinson’s disease

N. Drummond, K. Udupa, U. Saha, T. Hoque, J. Saravanamuttu, A. Fasano, A. Lozano, M. Hodaie, S. Kalia, R. Chen (Toronto, ON, Canada)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions

F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

Parkinson's Disease: Non-Motor Symptoms  ·  Hall 3FG

1:15pm-2:45pm

Longitudinal changes in Neuromelanin MRI Signal in Parkinson’s Disease

R. Gaurav, N. Pyatigorskaya, C. Ewenczyk, R. Valabregue, K. Evans, I. Arnulf, M. Vidailhet, S. Lehéricy (Paris, France)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG

1:15pm-2:45pm

Longitudinal decline in white matter integrity in Parkinson’s disease: An analysis of Parkinson Progression Markers Initiative diffusion tensor imaging data

K. Taylor, F. Sambataro, A. Bertolino, J. Dukart (Basel, Switzerland)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Hall 3FG